Search results
Obesity and Weight Loss
Author(s):
C Richard Conti
Added:
3 years ago
Article
Author(s):
Michael Hecht Olsen
Added:
3 years ago
Shortcomings of Traditional Cardiovascular Risk Factors
Many years of epidemiological and clinical cardiovascular research has taught us which risk factors typically lead to the development of cardiovascular disease (CVD). Since the damaging effects of these traditional cardiovascular risk factors are partly additive, researchers have developed different tools to assess cardiovascular risk in…
View more
Author(s):
Markus P Schlaich
,
Murray D Esler
Added:
3 years ago
The pathogenesis of primary hypertension is multifactorial. However, the sympathetic nervous system plays an important role in circulatory and metabolic control and has clearly been established as a major contributor to the development of hypertension, with blood pressure elevation being initiated and sustained by elevated sympathetic nervous activity. Increased sympathetic outflow to the heart…
View more
Author(s):
Peter M Nilsson
Added:
3 years ago
Some cardiovascular (CV) risk-prone patients are easy to recognise, for example following manifestations of cardiovascular disease (CVD), coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) interventions, and they deserve appropriate risk-factor control for secondary prevention, including blood pressure (BP) lowering. However, many other at-risk patients…
View more
Author(s):
Niels Voigt
,
Dobromir Dobrev
Added:
3 years ago
Atrial fibrillation (AF) is common and is associated with significant cardiovascular morbidity and mortality, with stroke being the most critical complication.1,2 Drugs presently used for AF therapy have major limitations, including incomplete efficacy and risks of life-threatening proarrhythmic events (antiarrhythmic drugs) and bleeding complications (anticoagulants).3 Non-pharmacological…
View more
Author(s):
Christoph Maack
,
Michael Böhm
Added:
3 years ago
Chronic heart failure is the leading cause of hospitalisation in Germany1 and other European countries. It is the result of various cardiovascular diseases, such as myocardial infarction, arterial hypertension and valvular heart diseases. About 50 % of patients with heart failure have normal systolic, but impaired diastolic function, a condition termed heart failure with preserved ejection…
View more
Author(s):
Eliecer Coto
,
Pablo Avanzas
,
Juan Gómez
Added:
3 years ago
Author(s):
Luis M Ruilope
Added:
3 years ago
Globally, an estimated 26.4% of the adult population suffers from hypertension, and this figure is set to rise by 3% by 2025.1 The condition is asymptomatic and is often dubbed the ‘silent killer’ because it frequently goes undetected. The clinical significance of hypertension stems from the increased risk of end organ damage due to elevated blood pressure (BP) (see Figure 1). Chronic high BP is…
View more
Author(s):
Mark CS Hall
,
Johan EP Waktare
Added:
3 years ago
Introduction
Since the inception of cardiac pacing, the favoured site has been the right ventricular apex (RVA). The RVA is popular as it is usually straightforward, provides stable lead position and is associated with few complications.
A critical re-evaluation of this practice is occurring, however. There is accumulating evidence that RVA pacing causes adverse effects on left ventricular (LV)…
View more
New Trends and Developments in Patients with Severe Aortic Stenosis - Towards Optimal Treatment?
Author(s):
Martijn WA van Geldorp
,
Johanna JM Takkenberg
,
Ad JJC Bogers
,
et al
Added:
3 years ago
Article